J. Bartlett

发表

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

G. M. Ortiz, D. Nixon, L. Kostrikis, 2002, AIDS.

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

D. Montefiori, G. M. Ortiz, D. Nixon, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

S W Lagakos, M. Hirsch, T. Merigan, 1990 .

Associations Between HLA-DRB1*0102, HLA-B*5801, and Hepatotoxicity During Initiation of Nevirapine-Containing Regimens in South Africa

M. Lederman, I. James, S. Mallal, 2013, Journal of acquired immune deficiency syndromes.

Etiology of Severe Non-malaria Febrile Illness in Northern Tanzania: A Prospective Cohort Study

John A. Bartlett, J. Crump, J. Bartlett, 2013, PLoS neglected tropical diseases.

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

M. Lederman, J. Bartlett, G. Maartens, 2005, The Journal of infectious diseases.

Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)

J. Hoffman, J. Bartlett, H. Waskin, 1996, International journal of STD & AIDS.

Individual and partner characteristics associated with HIV testing and counseling uptake among individuals 50 years or older in Tanzania

J. Bartlett, M. Mahande, H. Ramadhani, 2019, International journal of STD & AIDS.

HIV Infection: Treatment Outcomes in Older and Younger Adults

K. Schmader, M. Wellons, J. Bartlett, 2002, Journal of the American Geriatrics Society.

Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.

D. Katzenstein, J. Bartlett, N. Kumarasamy, 2016, The Journal of infectious diseases.

Leptospirosis among hospitalized febrile patients in northern Tanzania.

J. Crump, J. Bartlett, S. Shadomy, 2011, The American journal of tropical medicine and hygiene.

Safety and immunogenicity of an HLA‐based HIV envelope polyvalent synthetic peptide immunogen

B. Haynes, J. Bartlett, C. Tacket, 1998 .

Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care, in the Kilimanjaro Region of Tanzania (2003–2005)

J. Crump, J. Bartlett, N. Thielman, 2009, Annals of tropical medicine and parasitology.

Characteristics of HIV Voluntary Counseling and Testing Clients Before and During Care and Treatment Scale-Up in Moshi, Tanzania

J. Crump, J. Bartlett, N. Thielman, 2009, Journal of acquired immune deficiency syndromes.

Antiretroviral Treatment Literacy Among HIV Voluntary Counseling and Testing Clients in Moshi, Tanzania, 2003 to 2005

J. Crump, J. Bartlett, N. Thielman, 2007, Journal of the International Association of Physicians in AIDS Care.

Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania.

J. Crump, J. Bartlett, N. Thielman, 2006, American journal of public health.

Invasive Disease Caused by Nontuberculous Mycobacteria, Tanzania

J. Crump, J. Bartlett, D. van Soolingen, 2009, Emerging infectious diseases.

Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania.

C. Hamilton, J. Crump, J. Bartlett, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Prevalence of Multidrug Resistant UTI Among People Living with HIV in Northern Tanzania

B. Sunguya, J. Bartlett, B. Mmbaga, 2021, Infection and drug resistance.

HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.

J. Bartlett, A. Phillips, A. Hill, 1996, AIDS.

A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania

C. Hamilton, S. Chow, J. Crump, 2014, BMC Infectious Diseases.

Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12

J. Bartlett, R. Bosch, E. Adams, 2004, AIDS.

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection

J. Bartlett, A. Chow, F. Wong, 1994, Antimicrobial Agents and Chemotherapy.

Cancer spectrum in HIV-infected patients: A zonal hospital experience in Tanzania.

J. Bartlett, B. Mmbaga, Alex Mremi, 2020, Cancer Treatment and Research Communications.

Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.

J. Crump, J. Bartlett, N. Thielman, 2009, AIDS research and human retroviruses.

The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis.

J. Bartlett, J. Vissoci, M. V. van Agtmael, 2019, Life sciences.

Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection

J. Bartlett, Albert M Anderson, Albert M. Anderson, 2005, Expert review of anti-infective therapy.

Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV

J. Bartlett, Dorothy E. Dow, Dorothy E. Dow, 2014, Infectious Diseases and Therapy.

Decreasing CD4+ T-cell Count During Suppressed or Low-Level Viraemia in Patients with HIV Infection

J. Bartlett, A. Kosinski, Albert M Anderson, 2007, Antiviral therapy.

Comparative Efficacy of Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Combination with Efavirenz: Results of a Systematic Overview

J. Bartlett, Shan-Shan Chen, J. Quinn, 2007, HIV clinical trials.

Minimizing Resistance Consequences After Virologic Failure on Initial Combination Therapy: A Systematic Overview

R. Elston, J. Bartlett, M. King, 2006, Journal of acquired immune deficiency syndromes.

Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients.

J. Crump, J. Bartlett, D. Asmuth, 2008, East African medical journal.

A Prospective Clinical and Pathological Examination of Injection Site Reactions with the HIV-1 Fusion Inhibitor Enfuvirtide

J. Bartlett, R. Hall, S. A. Myers, 2006, Antiviral therapy.

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction

J. Bartlett, A. Heald, P. Hsyu, 1996, Antimicrobial agents and chemotherapy.

Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.

J. Bartlett, D. Tyler, H. Lyerly, 1990, Journal of immunology.

Extra‐Intestinal Manifestations of Salmonella Infections

J. Bartlett, J. Cohen, G. Corey, 1987, Medicine.

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.

J. Bartlett, H. Waskin, H. Gallis, 1991, Reviews of infectious diseases.

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.

F. Hecht, J. Bartlett, K. Squires, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Sociodemographic and clinical characteristics of clients presenting for HIV voluntary counselling and testing in Moshi, Tanzania.

J. Crump, J. Bartlett, N. Thielman, 2005, International journal of STD & AIDS.

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.

B. Haynes, J. Bartlett, C. Tacket, 1998, AIDS.

Primary care for patients infected with human immunodeficiency virus

J. Bartlett, E. Oddone, T. Box, 2001, Journal of General Internal Medicine.

HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.

J. Bartlett, F. Cai, E. Turner, 2017, AIDS research and human retroviruses.

HIV Resistance with Correlation to PMTCT Regimen in HIV-Infected Infants in Northern Tanzania

J. Bartlett, F. Cai, E. Turner, 2017 .

13-AVT-1022 Myers

J. Bartlett, R. Hall, S. A. Myers, 2006 .

Feeding Alzheimer's patients

J. Bartlett, K. Kolasa, Catherine A. Schmidt, 1989 .

Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials

J. Bartlett, J. Eron, G. E. Pakes, 1999, Antimicrobial Agents and Chemotherapy.

Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

D. Kuritzkes, J. Bartlett, S. Riddler, 2009, AIDS research and human retroviruses.

CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.

J. Bartlett, D. Bolognesi, M. Greenberg, 1993, AIDS research and human retroviruses.

Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus

J. Bartlett, S. Weller, H. Gallis, 1989, Antimicrobial Agents and Chemotherapy.

HIV therapeutics: an emerging science.

J. Bartlett, 1988, JAMA.

Naïve T Cells Are Maintained in the Periphery During the First3 Months of Acute HIV-1 Infection: Implications for Analysis of Thymus Function

B. Haynes, J. Bartlett, G. Ferrari, 2005, Journal of Clinical Immunology.

Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages

J. Bartlett, D. Bolognesi, T. Matthews, 1991, Journal of virology.

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1

J. Perfect, J. Bartlett, H. Waskin, 1993, Antimicrobial Agents and Chemotherapy.

Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.

J. Bartlett, D. Tyler, D. Bolognesi, 1998, The Journal of surgical research.

Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes.

J. Bartlett, J. Hiscott, Y. Mamane, 2000, AIDS research and human retroviruses.

Reply to 'Quantification of HIV-1 RNA on Dried Blood Spots' AIDS 24:475-6.

J. Crump, J. Bartlett, S. Lofgren, 2010, AIDS.

Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.

J. Crump, J. Bartlett, N. Thielman, 2007, AIDS research and human retroviruses.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

J. L. Harmon, B. Haynes, W. Wilkinson, 2000, AIDS research and human retroviruses.

Predicting Virologic Failure Among HIV-1-Infected Children Receiving Antiretroviral Therapy in Tanzania: a Cross-Sectional Study

J. Crump, J. Bartlett, Elizabeth A. Reddy, 2010, Journal of acquired immune deficiency syndromes.

Oropharyngeal yeast flora and fluconazole resistance in HIV‐infected patientsreceiving long‐term continuous versus intermitent fluconazole therapy

J. Perfect, J. Bartlett, W. Schell, 1996, AIDS.

Open-label titration study of the safety of RMP-7 in patients with the acquired immune deficiency syndrome.

J. Bartlett, W. Graney, N. Anstey, 1996, International journal of antimicrobial agents.

HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature.

J. Bartlett, M. Telen, K. Roberts, 1990, Journal of acquired immune deficiency syndromes.

Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities

J. Crump, J. Bartlett, S. Lofgren, 2009, AIDS.

Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.

Shein-Chung Chow, S. Chow, J. Crump, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chest radiography for predicting etiology of febrile illness among inpatients in Moshi, Tanzania

J. Crump, J. Bartlett, S. Fiorillo, 2013 .

HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania

J. Crump, J. Bartlett, J. Hamilton, 2004, Annals of tropical medicine and parasitology.

Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.

G. Pantaleo, J. Bartlett, R. Steigbigel, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Long-Term Results of Initial Therapy With Abacavir and Lamivudine Combined With Efavirenz, Amprenavir/Ritonavir, or Stavudine

J. Bartlett, D. Irlbeck, N. Sosa, 2006, Journal of acquired immune deficiency syndromes.

Who Tests, Who Doesn't, and Why? Uptake of Mobile HIV Counseling and Testing in the Kilimanjaro Region of Tanzania

J. Crump, J. Bartlett, Elizabeth A. Reddy, 2011, PloS one.

Gender Differences in the Risk of HIV Infection among Persons Reporting Abstinence, Monogamy, and Multiple Sexual Partners in Northern Tanzania

J. Crump, J. Bartlett, N. Thielman, 2008, PloS one.

Psychiatric issues in non-anonymous oocyte donation. Motivations and expectations of women donors and recipients.

J. Bartlett, 1991, Psychosomatics.

Global Noncommunicable Disease Research: Opportunities and Challenges

G. Bloomfield, K. Narayan, D. Heimburger, 2015, Annals of Internal Medicine.

Associations between Methylation of Paternally Expressed Gene 3 (PEG3), Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer

S. Murphy, J. Bartlett, Jennifer S. Smith, 2013, PloS one.

Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.

J. Bartlett, E. Hersh, S. Landesman, 1991, JAMA.

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

J. Phair, M. Hirsch, S. Lagakos, 1994, JAMA.

Effect of Simultaneous Didanosine Administration on Itraconazole Absorption in Healthy Volunteers

J. Bartlett, R. Drew, D. May, 1994, Pharmacotherapy.

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.

J. Bartlett, H. Waskin, H. Gallis, 1991, Reviews of infectious diseases.

Central nervous system pneumocystosis in a patient with AIDS.

J. Bartlett, C. Hulette, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.

J. Crump, J. Bartlett, P. Goodman, 2013, Clinical radiology.

Invasive bacterial and fungal infections among hospitalized HIV‐infected and HIV‐uninfected children and infants in northern Tanzania

S. Chow, J. Crump, J. Bartlett, 2011, Tropical medicine & international health : TM & IH.

Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults

J. Bartlett, J. Mellors, S. Riddler, 1996, Antimicrobial agents and chemotherapy.

Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania.

J. Crump, J. Bartlett, V. Maro, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

Joseph Quinn, Franck Rousseau, J. Bartlett, 2006, AIDS.

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

Joseph Quinn, Franck Rousseau, John A. Bartlett, 2001, AIDS.

Predictors of proteinuria and renal failure among women with HIV infection.

Mardge H. Cohen, K. Anastos, M. Young, 2002, Kidney international.

Progress in the Prevention of Mother to Child Transmission of HIV in Three Regions of Tanzania: A Retrospective Analysis

J. Bartlett, C. Cunningham, Dorothy E. Dow, 2014, PloS one.

Taste and smell losses in HIV infected patients

S. Schiffman, J. Bartlett, B. G. Graham, 1995, Physiology & Behavior.

Persistent Antiretroviral Activity of Nucleoside Analogues After Prolonged Zidovudine and Lamivudine Therapy as Demonstrated by Rapid Loss of Activity After Discontinuation

V. Johnson, D. Kuritzkes, J. Bartlett, 2004, Journal of acquired immune deficiency syndromes.

Reductions in HIV‐1 disease progression for zidovudine/lamivudine relative to control treatments: a meta‐analysis of controlled trials

C. Katlama, J. Bartlett, S. Staszewski, 1997, AIDS.

Generic and Branded Drugs for the Treatment of People Living With HIV/AIDS

J. Bartlett, E. Muro, 2007, Journal of the International Association of Physicians in AIDS Care.

Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region

J. Crump, J. Bartlett, J. Gratz, 2010, Tropical medicine & international health : TM & IH.

Effects of HIV Infection on the Metabolic and Hormonal Status of Children with Severe Acute Malnutrition

J. Bartlett, C. Newgard, J. Bain, 2014, PloS one.

Progress in the understanding of HIV infection: an overview.

J. Bartlett, N. Prose, S. Myers, 1993, Journal of the American Academy of Dermatology.

Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.

M. Lederman, R. Kim, J. Bartlett, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy

E. Paoletti, J. Bartlett, W. Cox, 1997 .

IL‐7 enhancement of antigen‐driven activation/expansion of HIV‐1‐specific cytotoxic T lymphocyte precursors (CTLp)

J. Bartlett, G. Ferrari, D. Bolognesi, 1995, Clinical and experimental immunology.

Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.

B. Haynes, J. Bartlett, K. Weinhold, 2001, AIDS research and human retroviruses.

Anti-HIV substances for rape victims.

J. Bartlett, I. Foster, 1989, JAMA.

Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.

D. Gubler, J. Crump, J. Bartlett, 2012, The American journal of tropical medicine and hygiene.

Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up.

J. Bartlett, S. Shaunak, R. Albright, 1991, Journal of Infectious Diseases.

Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease.

J. Bartlett, S. Henry, J. Hamilton, 1990, Journal of Infectious Diseases.

Detection of minor drug-resistant populations by parallel allele-specific sequencing

Fangping Cai, J. Bartlett, F. Cai, 2007, Nature Methods.

Brucellosis among hospitalized febrile patients in northern Tanzania.

J. Crump, J. Bartlett, S. Cleaveland, 2012, The American journal of tropical medicine and hygiene.

Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy.

J. Crump, J. Bartlett, V. Maro, 2015, The American journal of tropical medicine and hygiene.

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis

S. Hammer, D. Katzenstein, R. Schooley, 2000 .

Strategies of antiretroviral therapy in adults.

J. Bartlett, S. Itani, 1998, The Urologic clinics of North America.

Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment.

J. Bartlett, A. Hill, R. Demasi, 1998, The Journal of infectious diseases.

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals

V. Johnson, D. Kuritzkes, J. Bartlett, 1997, AIDS.

HIV-1-associated thrombocytopenia. The role of splenectomy.

J. Bartlett, D. Tyler, J. Iglehart, 1990, Annals of surgery.

Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality.

J. Bartlett, C. Newgard, J. Bain, 2014, The Journal of clinical endocrinology and metabolism.

Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.

S. Chow, J. Crump, J. Bartlett, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.

G. D. Miralles, J. Bartlett, J. Ottinger, 2002, AIDS research and human retroviruses.

A Cost-Effectiveness Analysis of Alternative HIV Retesting Strategies in Sub-Saharan Africa

J. Crump, J. Bartlett, N. Thielman, 2011, Journal of acquired immune deficiency syndromes.

The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania

J. Bartlett, W. Miller, B. Pence, 2016, Open forum infectious diseases.

Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.

J. Crump, J. Bartlett, N. Thielman, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of First-Line and Second-Line Antiretroviral Therapy Adherence

J. Bartlett, W. Miller, B. Pence, 2014, Open forum infectious diseases.

Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania

J. Bartlett, C. Orrell, A. Boulle, 2017, PloS one.

Addressing the Challenges of Adherence

John A. Bartlett, J. Bartlett, 2002, Journal of acquired immune deficiency syndromes.

PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer

S. Murphy, J. Bartlett, Jennifer S. Smith, 2013, Clinical and Translational Oncology.

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

D. Katzenstein, J. Crump, J. Bartlett, 2012, AIDS.

Changing antiretroviral therapy in the setting of virologic relapse: Review of the current literature

J. Bartlett, Albert M. Anderson, 2006, Current HIV/AIDS reports.

Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.

J. Bartlett, J. F. Shao, 2009, The Lancet. Infectious diseases.

Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women

S. Murphy, J. Bartlett, Jennifer S. Smith, 2011, Infectious Agents and Cancer.

IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes

S. Murphy, J. Bartlett, J. Obure, 2015, Infectious Agents and Cancer.

Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.

M. Wellons, J. Bartlett, K. Weinhold, 2001, The Journal of infectious diseases.

Cancer disparities in people with HIV: A systematic review of screening for non‐AIDS–defining malignancies

J. Bartlett, G. Suneja, K. Corrigan, 2019, Cancer.

Changes in CD4+ T-Cell Differentiation Phenotype During Structured Treatment Interruption in Patients With Chronic HIV-1 Infection

S. Furlan, G. M. Ortiz, D. Nixon, 2003, Journal of acquired immune deficiency syndromes.

Erratum: Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection (The Journal of Clinical Investigation (1999) 103 (453- 460))

H. Liao, B. Haynes, A. Haase, 1999 .

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

H. Liao, B. Haynes, A. Haase, 1999, The Journal of clinical investigation.

Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230

D. Katzenstein, J. Bartlett, N. Kumarasamy, 2016, Open forum infectious diseases.

The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.

J. Bartlett, D. Tyler, D. Bolognesi, 1991, Cellular immunology.

Effect of a Triage‐Based Screening Protocol on Diagnosis and Treatment of Acute Coronary Syndrome in a Tanzanian Emergency Department: A Prospective Pre‐Post Study

G. Bloomfield, J. Bartlett, J. Bettger, 2020, Journal of the American Heart Association.

E. Paoletti, J. Bartlett, W. Cox, 1997, Blood.

Antiretroviral Treatment and Time Since HIV-1 Diagnosis are Associated with Large Artery Stiffness in Sub-Saharan African HIV-1 Patients

J. Bartlett, M. Agtmael, Y. Smulders, 2016 .

Drug susceptibility and resistance mutations after first-line failure in resource limited settings.

D. Katzenstein, J. Bartlett, W. Stevens, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

T. Merigan, G. D. Miralles, J. Bartlett, 2004, The Journal of infectious diseases.

Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania

J. Crump, J. Bartlett, L. Reller, 2008, Journal of acquired immune deficiency syndromes.

Stavudine in first-line antiretroviral regimens in resource-limited settings: time for a better solution

J. Bartlett, V. Maro, 2009 .

Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.

C. Fox, A. Fauci, G. Pantaleo, 1996, The Journal of infectious diseases.

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

D. Katzenstein, J. Crump, J. Bartlett, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3.

S. Lagakos, D. Richman, C. Pettinelli, 1990 .

Association of knowledge on ART line of treatment, scarcity of treatment options and adherence

J. Bartlett, V. Maro, H. Ramadhani, 2016, BMC Health Services Research.

Simultaneous pneumococcal and Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.

J. Bartlett, C. W. Ingram, 1990, Southern medical journal.

Lack of protease inhibitor resistance following treatment failure--too good to be true?

J. Bartlett, 2013, The Journal of clinical investigation.

Hyperlipidaemia in HIV-Infected Patients on Lopinavir/Ritonavir Monotherapy in Resource-Limited Settings

M. Hughes, J. Bartlett, M. Hosseinipour, 2016, Antiviral therapy.

Obstacles and Proposed Solutions to Effective Antiretroviral Therapy in Resource-Limited Settings

J. Hornberger, J. Bartlett, M. Bhor, 2009, Journal of the International Association of Physicians in AIDS Care.

Primary care of HIV infection.

J. Bartlett, D. Sexton, 1998, Hospital Practice.

A Randomized Study of Antiviral Medication Switch at Lower-Versus Higher-Switch Thresholds: AIDS Clinical Trials Group Study A5115

K. Tashima, D. Kuritzkes, J. Bartlett, 2007, Antiviral therapy.

Initiation of antiretroviral therapy in HIV‐infected adults with skin complaints in northern Tanzania

J. Crump, J. Bartlett, H. Grossmann, 2015, International journal of dermatology.

IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes

S. Murphy, J. Bartlett, J. Obure, 2015, Infectious Agents and Cancer.

Integrating Routine HIV Screening Into a Primary Care Setting in Rural North Carolina

J. L. Harmon, J. Barroso, J. Bartlett, 2014, The Journal of the Association of Nurses in AIDS Care : JANAC.

Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance

J. Bartlett, V. Maro, H. Ramadhani, 2018, AIDS and Behavior.

Prevalence and Outcome of HIV-associated Malignancies Among HIV-infected Children Enrolled into Care at Kilimanjaro Christian Medical Center 2006 to 2014: A Hospital-based Retrospective Analytical Study

J. Bartlett, B. Mmbaga, J. Ngocho, 2020, Journal of pediatric hematology/oncology.

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Tania B. Huedo-Medina, M. Hughes, P. Sax, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Does Antiretroviral Therapy Packaging Matter? Perceptions and Preferences of Antiretroviral Therapy Packaging for People Living with HIV in Northern Tanzania

J. Bartlett, H. Bosworth, H. Ramadhani, 2019, Patient preference and adherence.

Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study

J. Bartlett, M. V. van Agtmael, Y. Smulders, 2018, BMC Infectious Diseases.

Protease inhibitors are associated with a slowed progression of HIV-related renal diseases.

L. Svetkey, J. Bartlett, L. Szczech, 2002, Clinical nephrology.

Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042.

J. Bartlett, G. Petroni, K. Weinhold, 1998, The Journal of infectious diseases.

Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities

J. Crump, J. Bartlett, S. Lofgren, 2009, AIDS.

J. Crump, J. Bartlett, V. Maro, 2015, The American journal of tropical medicine and hygiene.